Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations: Results of a cross-over study

Blood Purification

Volumn 25, Issue 5-6, 2008, Pages 432-440

  Traut, Mario ^a   Haufe, Christoph C ^b   Eismann, Ulrike ^a   Deppisch, Reinhold M ^c   Stein, Günter ^a   Wolf, Gunter ^a,d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HELIOS KLINIKUM ERFURT   (Germany)

^c Gambro Research   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Amyloidosis; Beta 2 microglobulin; c fos; Cuprophan; Polyamide

Indexed keywords

BETA 2 MICROGLOBULIN; CUPROPHANE; INTERLEUKIN 1; MESSENGER RNA; POLYAMIDE; PROTEIN C FOS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BLOOD CELL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GRANULOCYTE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LYMPHOCYTE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; BLOOD CELLS; CASE-CONTROL STUDIES; CELLULOSE; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; NYLONS; RENAL DIALYSIS; RNA, MESSENGER;

EID: 38849112061     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110069     Document Type: Article

References (25)

1. 2-Microglobulin-derived amyloidosis: an update. Kidney Int 2001;59(suppl 78):S164-S171.
2. 2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. J Clin Invest 1996;98:1088-1094.
3. 2-Microglobulin serum concentrations and associated amyloidosis in dialysis patients. Nephrol Dial Transplant 1991;6(suppl 3):57-61.
4. 2-microglobulin level for the treatment of dialysis-related amyloidosis. Nephrol Dial Transplant 2001;16(suppl 4):31-35.
5. 2-microglobulin and c-fos mRNA: is there an influence of high- or lowflux dialyzer membranes? Kidney Int 2001;59(suppl 78):S177-S181.
6. 2-Microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyzer membrane. J Am Soc Nephrol 2002;13:S72-S77.
7. 2-microglobulin after hemodialysis. Kidney Int 1999;56:1571-1577.
8. 2-microglobulin removal during hemodiafiltration and hemofiltration. Nephrol Dial Transplant 1989;4:653-657.
9. Schwalbe S, Holzauer M, Schaeffer J, Galanski M, Koch KM, Floege J: β2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis? Kidney Int 1997;52:1077-1083.
10. 2-microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006;17:546-555.
11. Cheung AK, Levin NW, Greene T, Agodoa L, Bialey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G: Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003;14:3251-3263.
12. Pickett TM, Cruickshank A, Greenwood RN, Greenwood RN, Taube D, Davenport A, Farrington K: Membrane flux not biocompatibility determines beta-2-microglobulin levels in hemodialysis patients. Blood Purif 2002;20:161-166.
13. Koda Y, Nishi SI, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997;52:1096-1101.
14. Bommer J, Seelig P, Seelig R, Geerlings W, Bommer G, Ritz E: Determinants of plasma β2-microglobulin concentrations: possible relation to membrane biocompatibility. Nephrol Dial Transplant 1987;2:22-25.
15. 2- microglobulin kinetics: in vivo and in vitro studies. Nephrol Dial Transplant 1988;3:284-290.
16. Cheung AK: Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1990;1:150-161.
17. Zaoui P, Hakim RM: The effects of the dialysis membrane on cytokine release. J Am Soc Nephrol 1994;4:1711-1718.
18. Friedrich B, Alexander D, Janessa A, Häring HU, Lang F, Risler T: Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction. Kidney Int 2006;70:2124-2130.
19. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA: Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990;37:85-93.
20. Knudsen PJ, Leon J, Ng AK, Shaldon S, Floege J, Koch KM: Hemodialysis-related induction of beta-2-microglobulin and interleukin-1 synthesis and release by mono nuclear phagocytes. Nephron 1989;53:188-193.
21. Arizono K, Nomura K, Motoyama T, Matsushita Y, Matsuoka K, Miyazu R, Takeshita H, Fukui H: Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis. Blood Purif 2004;22(suppl 2):26-29.
22. Carreno MP, Rousseau Y, Poignet JL, Jahns G, Cholley B, Kazatchkine MD, Haeffner-Cavaillon N: Dissociation between beta-2-microglobulin and IL-1 production in hemodialyzed patients. Nephrol Dial Trans plant 1997;12:2365-2374.
23. 2-microglobulin subunit of HLA-A and HLA-B antigens. Proc Natl Acad Sci USA 1979;76:5834-5838.
24. 2- Microglobulin from serum associates with MH class I antigens on the surface of cultured cells. Nature 1984;308:642-645.
25. 2M and AGE-β2M in synovial fibroblasts and macrophages. Nephrol Dial Transplant 2003;18:46-53.